Rate Benchmarking
Compare your rates with similar providers.
Select a published rate, define comparable providers, and see where that rate falls in your market.
See a sample rate comparisonHCPCS J1426 is classified under Drugs Administered Other than Oral Method, in the Drugs, Administered by Injection subgroup.
| Key Fact | Detail |
|---|---|
| Service Type | Drugs Administered Other than Oral Method Drugs, Administered by Injection |
| Common Place of Service | 99Other POS |
| Hospital Outpatient Group (APC) | APC 9412 - Injection, casimersen, 10 mg |
| Surgery Center Payment (ASC) | K2 - Drug paid separately with a covered surgery, at the OPPS rate |
| Common Revenue Codes | 0636 |
| Medicaid Fee Schedule | $161.025 median of the 8 states in the free previewView Medicaid rates for J1426 |
| WAC Price | Lorem ipsum dolor sit amet consectetur Lorem ipsum dolor sit amet consectetur VisitBuyandBill.com |
| Related NDC Codes | • 60923022702 - AMONDYS 45 (casimersen) 50 mg/mL, injection |
National average reimbursement for HCPCS J1426 by major payers:

$150.61
BCBS / Anthem

$168.34
UnitedHealthcare

$167.22
Aetna

$169.40
Cigna
Choose a payer to see a sample of rates for HCPCS J1426.
Mainegeneral Medical Center, Mainegeneral Speciality Care
Mainegeneral Health
Lior Shabtai
North Shore-Lij Medical PC
Anne Arundel Medical Center
New York-Presbyterian/Lawrence Hospital
Lawrence Medical Associates PC
King'S Daughters Medical Center
Kings Daughters Medical Center
Choose your state and specialty to build a report from payer-published rates.
Looking for other data?
Rate Benchmarking
Select a published rate, define comparable providers, and see where that rate falls in your market.
See a sample rate comparisonPayer Contract Negotiation
Use your fee schedule and market benchmarks to set target rates and draft a letter for your payer.
See a sample payer proposalHCPCS J1426 vs. Other Drugs, Administered by Injection Codes
The table lists codes related to J1426. Select one to see its fee schedule.
| Code | Description |
|---|---|
| 60923022702-NDC | AMONDYS 45 (casimersen) 50 mg/mL, injection |
| J1411-HCPCS | Injection, etranacogene dezaparvovec-drlb, per therapeutic dose |
| J1426-HCPCS | Injection, casimersen, 10 mg |
| J1427-HCPCS | Injection, viltolarsen, 10 mg |
What is a fee schedule?
A fee schedule is a list of fixed prices that healthcare providers charge for specific services, including HCPCS J1426. These prices vary depending on payer type (Medicare, Medicaid, private insurance), geographic location, and provider contracts.
Understanding the J1426 fee schedule helps patients estimate costs and providers optimize billing for accurate reimbursements.
Factors that affect fee schedules
Medicare & Medicaid Rates
Government-set reimbursement amounts
Private Insurance Rates
Negotiated rates between providers and insurance companies
Geographic Location
Costs may be higher in urban areas.
Provider Type
Hospital providers may have different rates than private practice.
Bring your top codes (like HCPCS J1426) and we'll show you how you compare in 15 minutes or less.
Medicare's hospital outpatient payment system (OPPS) assigns HCPCS J1426 to APC 9412 (Injection, casimersen, 10 mg). An APC groups outpatient services that Medicare pays at the same base rate.
CMS lists HCPCS J1426 with ASC payment indicator K2: Drug paid separately with a covered surgery, at the OPPS rate.
Hospital price transparency files list HCPCS J1426 under these revenue codes: 0636. A revenue code names the hospital department or charge category for the line; it does not change what the service is.